✦ LIBER ✦

Is distinct EGFR mutation status proof of second simultaneous primary non-small cell lung cancer?

✍ Scribed by Petrausch, Ulf; Tischler, Verena; Weder, Walter; Stahel, Rolf; Soltermann, Alex

Book ID: 113100556
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 790 KB
Volume: 5
Category: Article
ISSN: 1865-5041
DOI: 10.1007/s12254-012-0026-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR point mutation in non-small cell lu

EGFR point mutation in non-small cell lung cancer is occasionally accompanied by a second mutation or amplification

✍ Toshihiko Yokoyama; Masashi Kondo; Yasuhiro Goto; Takayuki Fukui; Hiromu Yoshiok 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Influence of Chemotherapy on EGFR Mutati

Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer

✍ Bai, H.; Wang, Z.; Chen, K.; Zhao, J.; Lee, J. J.; Wang, S.; Zhou, Q.; Zhuo, M.; 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 975 KB

Influence of first-line chemotherapy and

Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer

✍ Wu, Jenn-Yu; Yu, Chong-Jen; Shih, Jin-Yuan; Yang, Chih-Hsin; Yang, Pan-Chyr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Clinical outcome of patients with non-sm

Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status

✍ Kalikaki, Aristea; Koutsopoulos, Anastasios; Hatzidaki, Dora; Trypaki, Maria; Ko 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Increased epidermal growth factor recept

Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: A chromogenic in situ hybridization study of 182 patients

✍ CHANG, J; LIU, H; HSIEH, M; FANG, Y; HSIEH, M; HSIEH, J; CHIU, Y; TSAI, H; CHEN, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 701 KB

Better survival with EGFR exon 19 than e

Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals

✍ Jian-quan Zhu; Wen-zhao Zhong; Guo-chun Zhang; Rong Li; Xu-chao Zhang; Ai-lin Gu 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 801 KB